ID Week

Shorts

Ancillary Benefits of Clinical Trials
0:22
Ancillary Benefits of Clinical Trials
14 days ago
by
Arif R. Sarwari, MD, MSc, MBA(+1 more)
Conducting Trials in Rural Areas
0:22
Conducting Trials in Rural Areas
19 days ago
by
Arif R. Sarwari, MD, MSc, MBA(+1 more)
Do the New Hepatitis B Birth Dose Guidelines Miss Horizontal Transmission?
0:35
Do the New Hepatitis B Birth Dose Guidelines Miss Horizontal Transmission?
23 days ago
by
Karen B. Jacobson, MD, MPH(+1 more)
Why Preserving Amikacin and Macrolide Susceptibility Matters in MAC Lung Disease
0:32
Why Preserving Amikacin and Macrolide Susceptibility Matters in MAC Lung Disease
23 days ago
by
Kevin Winthrop, MD(+1 more)
Hepatitis B’s Hidden Household Risk for Infants
1:11
Hepatitis B’s Hidden Household Risk for Infants
24 days ago
by
Karen B. Jacobson, MD, MPH(+1 more)
Should You Test MAC Isolates for Susceptibility Every Time?
0:52
Should You Test MAC Isolates for Susceptibility Every Time?
24 days ago
by
Kevin Winthrop, MD(+1 more)
Why the Hepatitis B Birth Dose Is the Most Feasible Protection
0:33
Why the Hepatitis B Birth Dose Is the Most Feasible Protection
25 days ago
by
Karen B. Jacobson, MD, MPH(+1 more)
Why ENCORE Tested Inhaled Amikacin From the Start of MAC Treatment
0:36
Why ENCORE Tested Inhaled Amikacin From the Start of MAC Treatment
25 days ago
by
Kevin Winthrop, MD(+1 more)

Latest Content

Contagion attended IDWeek, and here are some of the top stories we reported on while we were there. Continue to catch our coverage in the days to follow!

Heather Yun, MD, FACP, FIDS who is this year’s IDWeek Chair for the Infectious Diseases Society of America (IDSA) talks about the honor of the position, the collective effort to put together the conference, and offers insights on AMR during war, as well as new emerging infectious disease threats.